Sun Pharma Advanced Research Company Limited Capital Reinvestment Ratio
Sun Pharma Advanced Research Company Limited capital reinvestment ratio. Sun Pharma Advanced Research Company Limited (SPARC) has a Capital Reinvestment Ratio of 0.79x as of September 2023, meaning it reinvests 1% of its operating cash flow (Rs63.60 Million) in capital expenditures (Rs50.40 Million). Check total reinvestment intensity of Sun Pharma Advanced Research Company Lim to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Sun Pharma Advanced Research Company Limited (2009–2014)
Capital reinvestment ratio of Sun Pharma Advanced Research Company Limited from 2009 to 2014. This chart tracks Sun Pharma Advanced Research Company Limited's Capital Reinvestment Ratio across 4 annual periods. Also explore Sun Pharma Advanced Research Company Lim (SPARC) net asset momentum to track the company's year-over-year net asset growth rate.
Sun Pharma Advanced Research Company Limited Capital Reinvestment Ratio by Year (2009–2014)
Sun Pharma Advanced Research Company Limited capital reinvestment ratio by year from 2009 to 2014. For the full cash flow conversion analysis, see SPARC cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2014 | 0.10x | Rs368.95 Million | Rs36.74 Million | ▼ -94.7% |
| 2011 | 1.89x | Rs25.05 Million | Rs47.34 Million | ▲ +191.8% |
| 2010 | 0.65x | Rs126.34 Million | Rs81.83 Million | ▼ -37.2% |
| 2009 | 1.03x | Rs254.54 Million | Rs262.35 Million | — |